Kristina Bram Knudsen, PhD, ERT

Kristina Bram Knudsen, PhD, ERT has a diverse work experience spanning over several industries. Kristina is currently the Director, Head of Non-clinical Safety and Toxicology at Nykode Therapeutics. Prior to this position, they worked as a Project Manager at Evaxion Biotech A/S. Kristina also served as a Senior Toxicologist at SAXOCON A/S, where they performed toxicological assessments and risk assessments for medical devices. At Novo Nordisk, they were a Senior Scientist in the Department of Early Regulatory Toxicology, responsible for setting up toxicity studies and interpreting safety issues related to compounds. Kristina has also worked as a Postdoc at Det Nationale Forskningscenter for Arbejdsmiljø (NFA/NRCWE), conducting in vivo toxicity testing of nanomaterials. Kristina started their career as a PhD student at Lundbeck, specializing in toxicological assessments of nanoparticles for drug delivery. Additionally, they have experience as a Research Assistant at the Danish Cancer Society and as a Substitute at VWR International. Kristina's academic background includes volunteering at the University of Pittsburgh and the University of New South Wales, where they conducted research in cancer and immunology.

Kristina Bram Knudsen, PhD, ERT completed their education in a chronological order as follows:

From 1999 to 2002, they attended Roskilde Amtsgymnasie, where they focused on the study of Mathematics. However, no specific degree was mentioned during this time.

Kristina then pursued higher education at Den Kgl. Veterinær- og Landbohøjskole from 2002 to 2007, where they obtained a Cand.Scient degree in Biology-Biotechnology.

Finally, from 2009 to 2013, they enrolled at Københavns Universitet - University of Copenhagen, where they successfully obtained their PhD in the field of Pharmacology and Toxicology.

These are the known educational achievements of Kristina Bram Knudsen, PhD, ERT, based on the provided information.